Soleno TherapeuticsSLNO
13F holders, Q1 2024 (March 31)1holders
$42.80avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Soleno Therapeutics Inc. (SLNO) in their 13F filings. The largest holder was TCG Crossover Management, LLC ($23.5M).
- Company
- Soleno Therapeutics Inc.
- CUSIP
- 834203200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $23.5M |
| Exits | 0 | $0 |
Ownership 1 holders
| TCG Crossover Management, LLC | 1.86% | New | 550,000 | $23.5M |
"% of holder's portfolio" is SLNO's weight in each manager's 13F, not the share of Soleno Therapeutics Inc. the manager owns.